share_log

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results

SEC ·  Mar 14, 2023 19:32
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more